MedTrace Logo

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

NCT07717385 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-07-21

No results posted yet for this study

Summary

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

Conditions

  • Psychological Stress
  • Sleep Disturbance
  • Anxiety Symptoms
  • Depressive Symptoms
  • Occupational Burnout

Interventions

DIETARY_SUPPLEMENT

Neuralli Mood

Two acid-resistant capsules taken once daily for 90 days. Each daily dose contains 30 billion CFU of L. plantarum PS128 and 20 billion heat-treated cells of L. paracasei PS23. Other ingredients include microcrystalline cellulose, hypromellose, pectin, glycerol, silica, and magnesium stearate.

Sponsors & Collaborators

  • Bened Life

    collaborator UNKNOWN

  • Efforia, Inc

    lead INDUSTRY

Principal Investigators

  • Matthew Amsden · Efforia, Inc

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-09-28
Completion
2027-09-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07717385 on ClinicalTrials.gov